The Food and Drugs Authority (FDA) has called on the public to disregard any medical products including in-vitro diagnostic purported to prevent, detect, treat or cure COVID-19.
The Authority warned all actors in the medical product supply chain to conduct due diligence on all products intended for the diagnosis or treatment of COVID-19.
This was in a statement signed by Mrs Delese A.Darko, the Chief Executive Officer, FDA and copied to the Ghana News Agency in Accra.
The statement said the Authority received a notification through the World Health Organization Rapid Alert system on falsified medical products including the in-vitro diagnostics.
The statement urged all actors in the medical product supply chain to clarify with the Authority any suspicious product intended for diagnosis or treatment of COVID-19.
It said medicinal products should be registered with the FDA before usage and imported only through Tema Habour and Kotoka International Airport.
“We wish to assure the public that our officers in the regions are working to ensure that the products do not get into our supply chain”, it said.
- Expanding Africa’s vaccine production capacity key – Noguchi Director
- Dengue fever epidemic declared in Burkina Faso
- Frontiers earned over $87m while government got under $7m from COVID testing at KIA – Report
- I donated PPE worth over $1 million during COVID-19 pandemic – Ken Agyapong
- Ablakwa releases ‘inaccessible details’ of contract awarded to Frontiers for COVID test at the airport
- Read all related articles